Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 500 entries
Sorted by: Best Match Show Resources per page
Evaluation of head and neck cancer with (18)F-FDG PET: a comparison with conventional methods.

European journal of nuclear medicine

Kresnik E, Mikosch P, Gallowitsch H, Kogler D, Wieser S, Heinisch M, Unterweger O, Raunik W, Kumnig G, Gomez I, Grünbacher G, Lind P.
PMID: 24770459
Eur J Nucl Med. 2001 Jul;28(7):816-21. doi: 10.1007/s002590100554.

The aim of this study was to evaluate the usefulness of (18)F-FDG PET in the diagnosis and staging of primary and recurrent malignant head and neck tumours in comparison with conventional imaging methods [including ultrasonography, radiography, computed tomography (CT)...

Cite
Kresnik E, Mikosch P, Gallowitsch H, et al. Evaluation of head and neck cancer with (18)F-FDG PET: a comparison with conventional methods. Eur J Nucl Med. 2001;28(7):816-21doi: 10.1007/s002590100554.
Kresnik, E., Mikosch, P., Gallowitsch, H., Kogler, D., Wieser, S., Heinisch, M., Unterweger, O., Raunik, W., Kumnig, G., Gomez, I., Grünbacher, G., & Lind, P. (2001). Evaluation of head and neck cancer with (18)F-FDG PET: a comparison with conventional methods. European journal of nuclear medicine, 28(7), 816-21. https://doi.org/10.1007/s002590100554
Kresnik, E, et al. "Evaluation of head and neck cancer with (18)F-FDG PET: a comparison with conventional methods." European journal of nuclear medicine vol. 28,7 (2001): 816-21. doi: https://doi.org/10.1007/s002590100554
Kresnik E, Mikosch P, Gallowitsch H, Kogler D, Wieser S, Heinisch M, Unterweger O, Raunik W, Kumnig G, Gomez I, Grünbacher G, Lind P. Evaluation of head and neck cancer with (18)F-FDG PET: a comparison with conventional methods. Eur J Nucl Med. 2001 Jul;28(7):816-21. doi: 10.1007/s002590100554. PMID: 24770459.
Copy Download .nbib Format: NLM
Relationship between expression of the sodium/iodide symporter and (131)I uptake in recurrent lesions of differentiated thyroid carcinoma.

European journal of nuclear medicine

Min JJ, Chung JK, Lee Y, Jeong J, Lee D, Jang J, Lee M, Cho B.
PMID: 24633540
Eur J Nucl Med. 2001 May;28(5):639-45. doi: 10.1007/s002590100509.

The sodium/iodide symporter (NIS) is known to be responsible for the active accumulation of iodide within the thyroid gland. We evaluated the relationship between the expression of NIS in primary or lymph node lesions and iodine-131 uptake in recurrent...

Cite
Min JJ, Chung JK, Lee Y, et al. Relationship between expression of the sodium/iodide symporter and (131)I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med. 2001;28(5):639-45doi: 10.1007/s002590100509.
Min, J. J., Chung, J. K., Lee, Y., Jeong, J., Lee, D., Jang, J., Lee, M., & Cho, B. (2001). Relationship between expression of the sodium/iodide symporter and (131)I uptake in recurrent lesions of differentiated thyroid carcinoma. European journal of nuclear medicine, 28(5), 639-45. https://doi.org/10.1007/s002590100509
Min, J J, et al. "Relationship between expression of the sodium/iodide symporter and (131)I uptake in recurrent lesions of differentiated thyroid carcinoma." European journal of nuclear medicine vol. 28,5 (2001): 639-45. doi: https://doi.org/10.1007/s002590100509
Min JJ, Chung JK, Lee Y, Jeong J, Lee D, Jang J, Lee M, Cho B. Relationship between expression of the sodium/iodide symporter and (131)I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med. 2001 May;28(5):639-45. doi: 10.1007/s002590100509. PMID: 24633540.
Copy Download .nbib Format: NLM
Correction to: Digital vs. analog PET/CT: intra-subject comparison of the SUVmax in target lesions and reference regions.

European journal of nuclear medicine and molecular imaging

Fuentes-Ocampo F, López-Mora DA, Flotats A, Paillahueque G, Camacho V, Duch J, Fernández A, Domènech A, Estorch M, Carrió I.
PMID: 30739142
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1204. doi: 10.1007/s00259-019-04280-0.

The article Digital vs. analog PET/CT: intra-subject comparison of the SUVmax in target lesions and reference regions, written by Francisco Fuentes-Ocampo, Diego Alfonso López-Mora, Albert Flotats, Gabriela Paillahueque.

Cite
Fuentes-Ocampo F, López-Mora DA, Flotats A, et al. Correction to: Digital vs. analog PET/CT: intra-subject comparison of the SUVmax in target lesions and reference regions. Eur J Nucl Med Mol Imaging. 2019;46(5):1204doi: 10.1007/s00259-019-04280-0.
Fuentes-Ocampo, F., López-Mora, D. A., Flotats, A., Paillahueque, G., Camacho, V., Duch, J., Fernández, A., Domènech, A., Estorch, M., & Carrió, I. (2019). Correction to: Digital vs. analog PET/CT: intra-subject comparison of the SUVmax in target lesions and reference regions. European journal of nuclear medicine and molecular imaging, 46(5), 1204. https://doi.org/10.1007/s00259-019-04280-0
Fuentes-Ocampo, Francisco, et al. "Correction to: Digital vs. analog PET/CT: intra-subject comparison of the SUVmax in target lesions and reference regions." European journal of nuclear medicine and molecular imaging vol. 46,5 (2019): 1204. doi: https://doi.org/10.1007/s00259-019-04280-0
Fuentes-Ocampo F, López-Mora DA, Flotats A, Paillahueque G, Camacho V, Duch J, Fernández A, Domènech A, Estorch M, Carrió I. Correction to: Digital vs. analog PET/CT: intra-subject comparison of the SUVmax in target lesions and reference regions. Eur J Nucl Med Mol Imaging. 2019 May;46(5):1204. doi: 10.1007/s00259-019-04280-0. PMID: 30739142.
Copy Download .nbib Format: NLM
Correction to: A rare presentation of skull-base osteomyelitis with neurovascular sheath extension following external otitis resolved by PET/MRI.

European journal of nuclear medicine and molecular imaging

Louarn N, Alias Q, Aupin L, Benoist N, Desroches M, Luciani A, Bresson D, Hodel J, Itti E.
PMID: 30218315
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2480-2481. doi: 10.1007/s00259-018-4157-2.

The figure in the original published version of this article was omitted.

Cite
Louarn N, Alias Q, Aupin L, et al. Correction to: A rare presentation of skull-base osteomyelitis with neurovascular sheath extension following external otitis resolved by PET/MRI. Eur J Nucl Med Mol Imaging. 2018;45(13):2480-2481doi: 10.1007/s00259-018-4157-2.
Louarn, N., Alias, Q., Aupin, L., Benoist, N., Desroches, M., Luciani, A., Bresson, D., Hodel, J., & Itti, E. (2018). Correction to: A rare presentation of skull-base osteomyelitis with neurovascular sheath extension following external otitis resolved by PET/MRI. European journal of nuclear medicine and molecular imaging, 45(13), 2480-2481. https://doi.org/10.1007/s00259-018-4157-2
Louarn, Nicolas, et al. "Correction to: A rare presentation of skull-base osteomyelitis with neurovascular sheath extension following external otitis resolved by PET/MRI." European journal of nuclear medicine and molecular imaging vol. 45,13 (2018): 2480-2481. doi: https://doi.org/10.1007/s00259-018-4157-2
Louarn N, Alias Q, Aupin L, Benoist N, Desroches M, Luciani A, Bresson D, Hodel J, Itti E. Correction to: A rare presentation of skull-base osteomyelitis with neurovascular sheath extension following external otitis resolved by PET/MRI. Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2480-2481. doi: 10.1007/s00259-018-4157-2. PMID: 30218315.
Copy Download .nbib Format: NLM
Correction to: Biological tumour volumes of gliomas in early and standard 20-40 min .

European journal of nuclear medicine and molecular imaging

Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL.
PMID: 29541813
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1078. doi: 10.1007/s00259-018-3991-6.

The name of M. Unterrainer was inadvertently presented as M. Unterrrainer in the original article.

Cite
Unterrainer M, Winkelmann I, Suchorska B, et al. Correction to: Biological tumour volumes of gliomas in early and standard 20-40 min . Eur J Nucl Med Mol Imaging. 2018;45(6):1078doi: 10.1007/s00259-018-3991-6.
Unterrainer, M., Winkelmann, I., Suchorska, B., Giese, A., Wenter, V., Kreth, F. W., Herms, J., Bartenstein, P., Tonn, J. C., & Albert, N. L. (2018). Correction to: Biological tumour volumes of gliomas in early and standard 20-40 min . European journal of nuclear medicine and molecular imaging, 45(6), 1078. https://doi.org/10.1007/s00259-018-3991-6
Unterrainer, M, et al. "Correction to: Biological tumour volumes of gliomas in early and standard 20-40 min ." European journal of nuclear medicine and molecular imaging vol. 45,6 (2018): 1078. doi: https://doi.org/10.1007/s00259-018-3991-6
Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL. Correction to: Biological tumour volumes of gliomas in early and standard 20-40 min . Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1078. doi: 10.1007/s00259-018-3991-6. PMID: 29541813.
Copy Download .nbib Format: NLM
Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis.

European journal of nuclear medicine and molecular imaging

Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H.
PMID: 27987029
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):559-560. doi: 10.1007/s00259-016-3598-8.

No abstract available.

Cite
Morbelli S, Arbizu J, Booij J, et al. Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis. Eur J Nucl Med Mol Imaging. 2017;44(3):559-560doi: 10.1007/s00259-016-3598-8.
Morbelli, S., Arbizu, J., Booij, J., Chen, M. K., Chetelat, G., Cross, D. J., Djekidel, M., Drzezga, A., Ekmekcioglu, O., Garibotto, V., Hesse, S., Ishii, K., Jafari, L., Lammertsma, A. A., Law, I., Mathews, D., Minoshima, S., Mosci, K., Pagani, M., Pappata, S., Silverman, D. H., Signore, A., Van De Giessen, E., Villemagne, V., Barthel, H. (2017). Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis. European journal of nuclear medicine and molecular imaging, 44(3), 559-560. https://doi.org/10.1007/s00259-016-3598-8
Morbelli, Silvia, et al. "Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis." European journal of nuclear medicine and molecular imaging vol. 44,3 (2017): 559-560. doi: https://doi.org/10.1007/s00259-016-3598-8
Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H. Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):559-560. doi: 10.1007/s00259-016-3598-8. PMID: 27987029.
Copy Download .nbib Format: NLM
Endogenous TSH levels at the time of .

European journal of nuclear medicine and molecular imaging

Vrachimis A, Riemann B, Mäder U, Reiners C, Verburg FA.
PMID: 26493309
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):224-231. doi: 10.1007/s00259-015-3223-2. Epub 2015 Oct 23.

PURPOSE: Based on a single older study it is established dogma that TSH levels should be ≥30 mU/l at the time of postoperative METHODS: A total of 1,873 patients without distant metastases referred for postoperative adjuvant RESULTS: Age, gender...

Cite
Vrachimis A, Riemann B, Mäder U, et al. Endogenous TSH levels at the time of . Eur J Nucl Med Mol Imaging. 2015;43(2):224-231doi: 10.1007/s00259-015-3223-2.
Vrachimis, A., Riemann, B., Mäder, U., Reiners, C., & Verburg, F. A. (2016). Endogenous TSH levels at the time of . European journal of nuclear medicine and molecular imaging, 43(2), 224-231. https://doi.org/10.1007/s00259-015-3223-2
Vrachimis, Alexis, et al. "Endogenous TSH levels at the time of ." European journal of nuclear medicine and molecular imaging vol. 43,2 (2016): 224-231. doi: https://doi.org/10.1007/s00259-015-3223-2
Vrachimis A, Riemann B, Mäder U, Reiners C, Verburg FA. Endogenous TSH levels at the time of . Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):224-231. doi: 10.1007/s00259-015-3223-2. Epub 2015 Oct 23. PMID: 26493309.
Copy Download .nbib Format: NLM
Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes.

European journal of nuclear medicine and molecular imaging

Kim JP, Kim J, Kim Y, Moon SH, Park YH, Yoo S, Jang H, Kim HJ, Na DL, Seo SW, Seong JK.
PMID: 32040609
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1611-1612. doi: 10.1007/s00259-020-04693-2.

The Table 2 in the original version of this article contained a mistake in the alignment. Correct Table 2 presentation is presented here.

Cite
Kim JP, Kim J, Kim Y, et al. Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes. Eur J Nucl Med Mol Imaging. 2020;47(6):1611-1612doi: 10.1007/s00259-020-04693-2.
Kim, J. P., Kim, J., Kim, Y., Moon, S. H., Park, Y. H., Yoo, S., Jang, H., Kim, H. J., Na, D. L., Seo, S. W., & Seong, J. K. (2020). Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes. European journal of nuclear medicine and molecular imaging, 47(6), 1611-1612. https://doi.org/10.1007/s00259-020-04693-2
Kim, Jun Pyo, et al. "Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes." European journal of nuclear medicine and molecular imaging vol. 47,6 (2020): 1611-1612. doi: https://doi.org/10.1007/s00259-020-04693-2
Kim JP, Kim J, Kim Y, Moon SH, Park YH, Yoo S, Jang H, Kim HJ, Na DL, Seo SW, Seong JK. Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes. Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1611-1612. doi: 10.1007/s00259-020-04693-2. PMID: 32040609; PMCID: PMC7645486.
Copy Download .nbib Format: NLM
Erratum to: Role of PET/CT in malignant pediatric lymphoma.

European journal of nuclear medicine and molecular imaging

Riad R, Omar W, Kotb M, Hafez M, Sidhom I, Zamzam M, Zaky I, Abdel-Dayem H.
PMID: 28058463
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):561. doi: 10.1007/s00259-016-3600-5.

No abstract available.

Cite
Riad R, Omar W, Kotb M, et al. Erratum to: Role of PET/CT in malignant pediatric lymphoma. Eur J Nucl Med Mol Imaging. 2017;44(3):561doi: 10.1007/s00259-016-3600-5.
Riad, R., Omar, W., Kotb, M., Hafez, M., Sidhom, I., Zamzam, M., Zaky, I., & Abdel-Dayem, H. (2017). Erratum to: Role of PET/CT in malignant pediatric lymphoma. European journal of nuclear medicine and molecular imaging, 44(3), 561. https://doi.org/10.1007/s00259-016-3600-5
Riad, Raef, et al. "Erratum to: Role of PET/CT in malignant pediatric lymphoma." European journal of nuclear medicine and molecular imaging vol. 44,3 (2017): 561. doi: https://doi.org/10.1007/s00259-016-3600-5
Riad R, Omar W, Kotb M, Hafez M, Sidhom I, Zamzam M, Zaky I, Abdel-Dayem H. Erratum to: Role of PET/CT in malignant pediatric lymphoma. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):561. doi: 10.1007/s00259-016-3600-5. PMID: 28058463.
Copy Download .nbib Format: NLM
Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.

European journal of nuclear medicine and molecular imaging

Aide N, Talbot M, Fruchart C, Damaj G, Lasnon C.
PMID: 29288275
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):675. doi: 10.1007/s00259-017-3915-x.

The formulae for Dice and Jaccard indices used to assess volumes concordance should read as follows.

Cite
Aide N, Talbot M, Fruchart C, et al. Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018;45(4):675doi: 10.1007/s00259-017-3915-x.
Aide, N., Talbot, M., Fruchart, C., Damaj, G., & Lasnon, C. (2018). Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. European journal of nuclear medicine and molecular imaging, 45(4), 675. https://doi.org/10.1007/s00259-017-3915-x
Aide, Nicolas, et al. "Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma." European journal of nuclear medicine and molecular imaging vol. 45,4 (2018): 675. doi: https://doi.org/10.1007/s00259-017-3915-x
Aide N, Talbot M, Fruchart C, Damaj G, Lasnon C. Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):675. doi: 10.1007/s00259-017-3915-x. PMID: 29288275; PMCID: PMC6828291.
Copy Download .nbib Format: NLM
Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study.

European journal of nuclear medicine and molecular imaging

Qiu DX, Li J, Zhang JW, Chen MF, Gao XM, Tang YX, Zhang Y, Yi XP, Yin HL, Gan Y, Wang GL, Zu XB, Hu S, Cai Y.
PMID: 34860277
Eur J Nucl Med Mol Imaging. 2021 Dec 03; doi: 10.1007/s00259-021-05636-1. Epub 2021 Dec 03.

PURPOSE: Growing evidence proved the efficacy of multi-parametric MRI (mpMRI) and prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT)-guided targeted biopsy (TB) in prostate cancer (PCa) diagnosis, but there is no direct comparison between mpMRI-TB and PSMA PET/CT-TB....

Cite
Qiu DX, Li J, Zhang JW, et al. Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2021;doi: 10.1007/s00259-021-05636-1.
Qiu, D. X., Li, J., Zhang, J. W., Chen, M. F., Gao, X. M., Tang, Y. X., Zhang, Y., Yi, X. P., Yin, H. L., Gan, Y., Wang, G. L., Zu, X. B., Hu, S., & Cai, Y. (2021). Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study. European journal of nuclear medicine and molecular imaging, . https://doi.org/10.1007/s00259-021-05636-1
Qiu, Dong-Xu, et al. "Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study." European journal of nuclear medicine and molecular imaging vol. (2021). doi: https://doi.org/10.1007/s00259-021-05636-1
Qiu DX, Li J, Zhang JW, Chen MF, Gao XM, Tang YX, Zhang Y, Yi XP, Yin HL, Gan Y, Wang GL, Zu XB, Hu S, Cai Y. Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2021 Dec 03; doi: 10.1007/s00259-021-05636-1. Epub 2021 Dec 03. PMID: 34860277.
Copy Download .nbib Format: NLM
International consensus on the use of tau PET imaging agent .

European journal of nuclear medicine and molecular imaging

Tian M, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, Garibotto V, Prior JO, Barthel H, Zhou R, Hou H, Dou X, Jin C, Zuo C, Zhang H.
PMID: 34978595
Eur J Nucl Med Mol Imaging. 2022 Jan 03; doi: 10.1007/s00259-021-05673-w. Epub 2022 Jan 03.

PURPOSE: Positron emission tomography (PET) with the first and only tau targeting radiotracer of METHOD: A multidisciplinary task group formed by experts from various countries discussed and approved the consensus for CONCLUSION: This international consensus and practice guideline will...

Cite
Tian M, Civelek AC, Carrio I, et al. International consensus on the use of tau PET imaging agent . Eur J Nucl Med Mol Imaging. 2022;doi: 10.1007/s00259-021-05673-w.
Tian, M., Civelek, A. C., Carrio, I., Watanabe, Y., Kang, K. W., Murakami, K., Garibotto, V., Prior, J. O., Barthel, H., Zhou, R., Hou, H., Dou, X., Jin, C., Zuo, C., Zhang, H. (2022). International consensus on the use of tau PET imaging agent . European journal of nuclear medicine and molecular imaging, . https://doi.org/10.1007/s00259-021-05673-w
Tian, Mei, et al. "International consensus on the use of tau PET imaging agent ." European journal of nuclear medicine and molecular imaging vol. (2022). doi: https://doi.org/10.1007/s00259-021-05673-w
Tian M, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, Garibotto V, Prior JO, Barthel H, Zhou R, Hou H, Dou X, Jin C, Zuo C, Zhang H. International consensus on the use of tau PET imaging agent . Eur J Nucl Med Mol Imaging. 2022 Jan 03; doi: 10.1007/s00259-021-05673-w. Epub 2022 Jan 03. PMID: 34978595.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 500 entries